Wilson Sonsini Goodrich & Rosati advised Cognito on the transaction. Neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here